Movement Disorders Clinical Trials

Find Movement Disorders Clinical Trials Near You

Precision Neuroimaging of Parkinson's Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Parkinson's Disease (PD) is a neurodegenerative disorder caused by dysfunction in both subcortical structures and the cortex. The investigators recently discovered a new brain system called the Somato-Cognitive Action Network (SCAN), which could be a primary locus of dysfunction in PD. Here, the investigators will use magnetic resonance imaging techniques in PD patients to test whether SCAN is critical for PD. The investigators will determine whether SCAN is connected to PD-relevant subcortical structures, and whether PD patients exhibit altered subcortical-to-SCAN connectivity. If successful, this work will identify SCAN as a specific circuit altered in PD patients that can serve as a new target for future neuromodulatory PD therapies.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: t
View:

• Must meet specific health and cognitive criteria depending on the group. For PD participants

• Clinical diagnosis of Parkinson's Disease

• Must not meet dementia criteria For Healthy Control Participants

• Normal or benign neurological exam

• Normal cognition

• No first-degree relatives with Parkinson's Disease

Locations
United States
Missouri
East Imaging Building
RECRUITING
St Louis
Contact Information
Primary
Ashley Meyer
ameyer29@wustl.edu
314-273-5426
Backup
Danny Bower
bower@wustl.edu
314-273-4429
Time Frame
Start Date: 2025-08-01
Estimated Completion Date: 2031-01
Participants
Target number of participants: 120
Treatments
Parkinson's Participants
* 70 non-demented individuals with clinically definite PD~* Must be 40 years of age or older~* Both male \& female
Healthy Control
* 50 individuals with normal neurological exams and cognition~* No first-degree relatives with PD~* Also, must be 40 years of age or older
Related Therapeutic Areas
Sponsors
Leads: Washington University School of Medicine
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)

This content was sourced from clinicaltrials.gov